|
|||||
|
|
Predicting a rapid response to adalimumab treatment and favorable short-term outcomes through the high platelet count in patients with ulcerative colitis: A multicenter retrospective cohort study |
|
| Authors: | Ryosuke Sakemi Maki Miyakawa Hiroki Tanaka Masanao Nasuno Satoshi Motoya Tokuma Tanuma Manabu Ishii Hideyuki Yanagisawa Masaki Yamashita Nariaki Toita Ryo Suzuki Toshihisa Kobayashi Masanori Nojima Suketo So |
| Abstract: | |
| Keywords: | adalimumab anti-tumor necrosis factor agent biologic therapy inflammatory bowel disease platelet count rapid response ulcerative colitis |